loading page

Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID-19 vaccination
  • snigdha nutalapati,
  • gerhard hildebrandt
snigdha nutalapati
University of Kentucky

Corresponding Author:[email protected]

Author Profile
gerhard hildebrandt
University of Kentucky
Author Profile


Vaccine mediated immune mediated thrombocytopenia (ITP) is an exceedingly rare. We present a 25-year-old female who developed severe refractory ITP with multiple active bleeding sites post second dose of COVID vaccination. She was treated with a combination of Romiplostim and Mycophenolate mofetil that resulted in rapid platelet count recovery.
29 Jun 2021Submitted to Clinical Case Reports
07 Jul 2021Submission Checks Completed
07 Jul 2021Assigned to Editor
08 Jul 2021Reviewer(s) Assigned
15 Aug 2021Review(s) Completed, Editorial Evaluation Pending
15 Aug 2021Editorial Decision: Revise Minor
06 Oct 20211st Revision Received
15 Oct 2021Submission Checks Completed
15 Oct 2021Assigned to Editor
15 Oct 2021Review(s) Completed, Editorial Evaluation Pending
16 Oct 2021Editorial Decision: Accept
Nov 2021Published in Clinical Case Reports volume 9 issue 11. 10.1002/ccr3.5035